Table 3.

Asthma Control in Children

	Well Controlled			Not Well Controlled			Very Poorly Controlled
Age (years)	0–4	5–11	>12	0–4	5–11	>12	0–4	5–11	≥12
Impairment
Symptoms days/week	≤ 2	≤ 2	≤ 2	> 2	> 2	> 2	throughout the day
Night awakening/month	1	≤ 1	≤ 2	> 1	≥ 2	1 to 3	> 1/wk	≥ 2	≥ 4
SABA/week	≤ 2	≤ 2	≤ 2	> 2	> 2	> 2	several times/day
Activity interference	none	none	none	some limitations			extremely limited
Lung function
FEV1 %	-	> 80	> 80	-	60 to 80	60 to 80	-	< 60	< 60
FEV1/FVC %	-	> 80		-	75 to 80		-	< 75
Questionnaire
ATAQ			0			1 to 2			3 to 4
ACQ			≤ 0.75			≥ 1.5			N/A
ACT			≥ 20			16 to19			≤ 15
Risk
Exacerbations/year	0 to 1	0 to 1	0 to 1	2 to 3	2 to 3	0 to 1	> 3	≥ 2	> 3

Modified from the 2007 NAEPP EPR-3. SABA- short acting beta2 agonist, FEV1-forced expiratory volume in 1 second, FVC- forced vital capacity.